Delivery Order SPE2DB24D2205-SPE2DB25FEDYH
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $13,846.97 on July 28, 2025, for the supply of Vyndamax 61 mg capsule unit dose packages (30-count) with a completion deadline of August 18, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $13,846.97 on April 24, 2025, for the supply of Vyndamax 61 mg capsule unit dose packages (30-count). The contract, which is not set-aside, carries a completion date of May 15, 2025, and operates under a firm fixed-price delivery order structure. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a $13,846.97 delivery order to AmerisourceBergen Drug Corp for Vyndamax 61 mg capsules (30-count unit dose packaging) with an ultimate completion date of August 22, 2025. This competitively awarded, firm fixed-price contract is classified as a non-set-aside and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $27,693.94 delivery order to AmerisourceBergen Drug Corp for Vyndamax 61 mg capsule unit dose packages (30-count) on September 11, 2025, with an ultimate completion date of October 2, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The vendor, headquartered in Conshohocken, Pennsylvania, will perform at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $13,846.97 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Vyndamax 61 mg capsule unit dose packages (30-count) with a firm fixed price structure. The contract, which is not set-aside, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 30, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $13,846.97 delivery order to AmerisourceBergen Drug Corp for Vyndamax 61 mg capsule unit dose packages (30-count) on September 18, 2025, with completion scheduled for October 9, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded a $13,846.97 delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Vyndamax 61 mg capsules in unit dose packages of 30 units. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 18, 2025, to be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Vyndamax 61 mg capsules (unit dose, 30-count packages) with a ceiling value of $55,387.88. This is a firm fixed price delivery order with an ultimate completion date of June 24, 2025, and represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location....
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Vyndamax 61 mg capsules in unit dose packaging (30-count). This firm fixed-price delivery order, valued at $13,846.97, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026. The...
- The Defense Logistics Agency awarded a $13,846.97 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Vyndamax 61 mg capsules in unit dose packaging (30-count). This is a firm fixed price delivery order with an ultimate completion date of July 11, 2025, and no set-aside designation was used in the competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEDYHDelivery Order
The Defense Logistics Agency awarded a $13,846.97 delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Vyndamax 61 mg capsules in unit dose packaging (30-count). The contract, which is not set-aside and carries a firm fixed price structure, is scheduled for ultimate completion by July 14, 2025. Performance will be executed from the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains an extensive portfolio of federal medical contracts with the Defense Logistics Agency. As a critical vendor for federal medical procurement, the company supplies a broad range of pharmaceutical products including brand-name and generic medications across multiple therapeutic domains to support military and veteran healthcare systems. The current delivery order for Vyndamax—a medication used to treat transthyretin amyloidosis—reflects the company's ongoing capability to fulfill federal pharmaceutical supply requirements through competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.8k | 6/20/25 |